05:18 PM EDT, 05/08/2024 (MT Newswires) -- Cytokinetics ( CYTK ) reported a Q1 net loss Wednesday of $1.33 per diluted share, narrower than the loss of $1.38 a year earlier.

Analysts polled by Capital IQ expected a loss of $1.14.

Revenue for the quarter ended March 31 was $835,000, down from $4.6 million a year earlier.

Analysts surveyed by Capital IQ expected $910,000.

Price: 65.80, Change: +0.53, Percent Change: +0.81